Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesCresco Labs Inc

Cresco Labs Inc

Healthcare Drug Manufacturers - Specialty & Generic
PortfolioPortfolio WatchlistWatchlist
Company price
0.5564 USD -0.01 ( 2.21%)
Last update at 2026-11-06T21:00:00Z
VOLUME
166153
Market Cap
275.17M

Momentum Score

…

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.56
Low
0.60
High
52 Week Price Range
0.59
Low
2.30
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Cresco Labs is a multi-state cannabis operator that cultivates, processes and distributes medical and adult-use cannabis products through wholesale and company-operated retail channels. Long-term growth may be supported by state-level legalization trends, expansion of retail distribution and product breadth, and scale advantages from consolidation in a fragmented industry. Investors may find the company attractive because it appears positioned to capture share through a diversified state footprint and integrated supply chain.
Key risks include federal illegality and regulatory uncertainty that limit banking access, impose adverse tax treatment under Section 280E, and leave results sensitive to state policy shifts and intense competition.

Risk Score
Medium

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.57
Dividend Yield
-
Revenue TTM
651.13M
Revenue Per Share
1.79
Gross Profit TTM
325.08M
Debt / Equity
-
ROE
-36.06%
Net Debt
366.68M
ROCE
7.01%
Diluted EPS TTM
-0.28

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -95.42M -10.62M -146.90M -126.91M -256.73M
Minority interest 4.64M -13.95M 4.33M 3.80M -22.76M
Net income -135.41M -74.44M -175.52M -212.05M -319.60M
Selling general administrative 247.45M 254.84M 274.63M 350.65M 317.80M
Gross profit 324.57M 364.45M 362.37M 407.01M 406.35M
Reconciled depreciation 55.74M 65.99M 69.30M 57.73M 44.95M
Ebit - - - 57.27M 111.98M
Ebitda - - - -10.66M -159.63M
Operating income 76.94M 109.28M 62.88M 56.93M 87.79M
Other operating expenses - - - - 16.00M
Interest expense 60.03M 57.52M 63.62M 58.52M 52.15M
Tax provision 44.62M 49.87M 32.95M 88.94M 40.11M
Interest income 3.75M 2.92M 2.80M 0.68M 0.94M
Net interest income -56.28M -54.60M -60.82M -57.84M -51.21M
Income tax expense - - - 89.10M 40.11M
Total revenue 655.85M 724.34M 770.88M 842.68M 821.68M
Total operating expenses 578.90M 615.06M 708.00M 785.75M 733.89M
Cost of revenue 331.28M 359.89M 408.52M 435.67M 415.33M
Total other income expense net -116.09M -65.30M -148.96M -126.00M -293.31M
Net income from continuing ops -140.04M -60.49M -179.85M -215.84M -296.83M
Net income applicable to common shares - - - -215.10M -319.60M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 1197.30M 1355.36M 1358.47M 1583.69M 1780.46M
Intangible assets 275.34M 293.99M 296.97M 407.59M 437.64M
Other current assets 19.91M 2.23M 2.87M 205.44M 16.88M
Total liab 944.80M 967.18M 930.40M 996.01M 982.73M
Total stockholder equity 252.50M 388.18M 428.07M 627.04M 755.55M
Other current liab - - - 281.02M 119.95M
Common stock - - - 588.43M 1597.71M
Capital stock 1722.28M 1706.82M 1689.45M 1704.63M 1597.71M
Retained earnings -1500.24M -1352.49M -1265.54M -1076.20M -841.91M
Other liab - - - - 110.32M
Good will 208.17M 283.48M 279.70M 330.56M 446.77M
Other assets - - - 139.78M 11.28M
Cash 57.90M 137.56M 103.43M 119.34M 223.54M
Total current liabilities 100.18M 94.34M 200.24M 281.02M 288.39M
Net debt 366.68M 332.51M 394.28M 349.71M 261.46M
Short long term debt 7.48M 9.32M 9.81M - 19.93M
Other stockholder equity - - - - -0.25M
Property plant equipment - - - 379.72M 452.89M
Total current assets 259.27M 294.26M 278.09M 326.95M 421.75M
Long term investments - - 0.73M 1.23M 5.91M
Net tangible assets - - - -149.72M -133.08M
Net receivables 37.89M 51.56M 51.07M 56.49M 44.69M
Long term debt 417.10M 460.75M 497.71M 469.06M 465.08M
Inventory 98.67M 83.34M 107.79M 134.61M 136.64M
Accounts payable 16.54M 13.65M 27.59M 28.09M 32.28M
Non currrent assets other 14.10M 14.99M 4.42M 9.44M 4.21M
Non current assets total 938.03M 1061.10M 1080.38M 1257.65M 1358.71M
Capital lease obligations 159.59M 169.57M 175.23M 191.62M 139.73M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -25.23M -44.59M -36.58M -163.93M
Change to liabilities - - - 0.00M 21.16M
Total cashflows from investing activities - - - - -163.93M
Net borrowings -59.74M -43.78M 16.69M - 160.75M
Total cash from financing activities -82.09M -71.48M -26.91M -86.64M 235.00M
Change to operating activities - - - - -22.74M
Net income -135.41M -74.44M -175.52M -215.10M -319.60M
Change in cash -49.92M 35.73M -12.99M -104.59M 85.33M
Begin period cash flow 144.25M 108.52M 121.51M 226.10M 140.77M
End period cash flow 94.33M 144.25M 108.52M 121.51M 226.10M
Total cash from operating activities 72.89M 132.48M 58.56M 18.74M 14.49M
Issuance of capital stock - - - 0.00M 124.11M
Depreciation 55.74M 65.99M 69.30M 57.73M 44.95M
Other cashflows from investing activities - - - - 33.16M
Change to inventory -18.00M 18.56M 23.49M -2.67M -18.42M
Change to account receivables 12.04M -1.73M -5.37M -14.78M -10.96M
Sale purchase of stock 0.00M -0.20M 0.00M - -
Other cashflows from financing activities - - - - -69.80M
Change to netincome - - - - 306.90M
Capital expenditures 38.18M 23.49M 57.88M 86.13M 93.88M
Change in working capital 26.81M 34.97M 15.22M 13.45M -29.07M
Stock based compensation 11.23M 14.16M 16.36M 23.22M 27.54M
Other non cash items -1.16M 6.33M 3.86M 9.62M -2.75M
Free cash flow 34.71M 108.99M 0.68M -67.39M -82.57M

Peer Comparison*

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
CRLBF
Cresco Labs Inc		 -0.01
2.21%		 0.56 - 105.26 0.42 0.77 1.29 62.53
MKKGY
Merck KGaA ADR		 -0.22
0.66%		 33.17 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 -2.76
1.62%		 167.12 24.86 15.11 3.13 1.98 3.08 18.89
TAK
Takeda Pharmaceutical Co Ltd ADR		 -0.17
0.80%		 21.02 - 10.96 0.01 1.20 2.94 23.11
TKPHF
Takeda Pharmaceutical Co. Ltd.		 -
-%		 41.85 - 10.66 0.01 1.16 2.94 23.11

Profile*

Cresco Labs Inc

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes, gummies, and pre-rolls under the Good News brand; vapes and edibles under the Wonder Wellness Co. brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand. The company offers cannabis flowers under the FloraCal brand; and cannabis oils and variety of bites are available at multiple potency levels under the Mindy's brand, as well as Loud*r brand. In addition, the company offers cannabis-infused edibles under the Sunnyside brand. The company is headquartered in Chicago, Illinois.

600 W. Fulton Street, Chicago, IL, United States, 60661

312 929 0993

https://www.crescolabs.com

2900

Name Title Year Born
Mr. Thomas J. Manning Exec. Chairman 1957
Mr. Charles Bachtell Co-Founder, CEO & Director 1979
Mr. Robert M. Sampson Co-Founder & Independent Director 1975
Mr. Dennis M. Olis Chief Financial Officer 1963
Mr. Ty Gent Chief Operating Officer 1959
Ms. Brenna Albert CPA Sr. VP and Controller of Accounting, Treasury & Tax NA
Mr. Zach Marburger Interim Chief Information Officer 1985
Jake Graves Mang. of Investor Relations NA
Mr. John Schetz Gen. Counsel 1977
Ms. Impola Kelli VP of Compliance NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…